211 related articles for article (PubMed ID: 24033587)
1. Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.
Deng C; Liu T; Wu K; Wang S; Li L; Lu H; Zhou T; Cheng D; Zhong X; Lu W
J Clin Pharm Ther; 2013 Dec; 38(6):480-9. PubMed ID: 24033587
[TBL] [Abstract][Full Text] [Related]
2. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
[TBL] [Abstract][Full Text] [Related]
3. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
4. External validation of population pharmacokinetic models of vancomycin in postoperative neurosurgical patients.
Wei S; Chen J; Zhao Z; Mei S
Eur J Clin Pharmacol; 2023 Aug; 79(8):1031-1042. PubMed ID: 37261482
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population.
Duong A; El Gamal A; Bilodeau V; Huot J; Delorme C; Poudrette J; Crevier B; Marsot A
Pharmacotherapy; 2024 Jun; 44(6):425-434. PubMed ID: 38803279
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
7. Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis.
Deng C; Liu T; Zhou T; Lu H; Cheng D; Zhong X; Lu W
Int J Clin Pharmacol Ther; 2013 May; 51(5):407-15. PubMed ID: 23458230
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Bayesian predictability of vancomycin concentration using population pharmacokinetic parameters in pediatric patients.
Ohnishi A; Yano Y; Ishibashi T; Katsube T; Oguma T
Drug Metab Pharmacokinet; 2005 Dec; 20(6):415-22. PubMed ID: 16415526
[TBL] [Abstract][Full Text] [Related]
9. External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients.
Guo T; van Hest RM; Roggeveen LF; Fleuren LM; Thoral PJ; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30833424
[TBL] [Abstract][Full Text] [Related]
10. Influences of renal function descriptors on population pharmacokinetic modeling of vancomycin in Chinese adult patients.
Ji XW; Ji SM; He XR; Zhu X; Chen R; Lu W
Acta Pharmacol Sin; 2018 Feb; 39(2):286-293. PubMed ID: 28836582
[TBL] [Abstract][Full Text] [Related]
11. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
[TBL] [Abstract][Full Text] [Related]
12. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.
Marsot A; Gallais F; Galambrun C; Coze C; Blin O; Andre N; Guilhaumou R
Paediatr Drugs; 2018 Aug; 20(4):375-381. PubMed ID: 29736878
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
[TBL] [Abstract][Full Text] [Related]
15. Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers.
Jing L; Liu TT; Guo Q; Chen M; Lu JJ; Lv CL
J Clin Pharm Ther; 2020 Feb; 45(1):88-96. PubMed ID: 31463971
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population.
Zhang R; Chen M; Liu TT; Lu JJ; Lv CL
Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):135-149. PubMed ID: 31541402
[TBL] [Abstract][Full Text] [Related]
17. Prediction of serum vancomycin concentrations using one-, two- and three-compartment models with implemented population pharmacokinetic parameters and with the Bayesian method.
Wu G; Furlanut M
J Pharm Pharmacol; 1998 Aug; 50(8):851-6. PubMed ID: 9751448
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic modeling and clinical application of vancomycin in Chinese patients hospitalized in intensive care units.
Lin Z; Chen DY; Zhu YW; Jiang ZL; Cui K; Zhang S; Chen LH
Sci Rep; 2021 Jan; 11(1):2670. PubMed ID: 33514803
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetic Modeling of Vancomycin in Thai Patients With Heterogeneous and Unstable Renal Function.
Jaisue S; Pongsakul C; D'Argenio DZ; Sermsappasuk P
Ther Drug Monit; 2020 Dec; 42(6):856-865. PubMed ID: 32947558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
